RECKITT BENCKISER GROUP PLC: Directorate Change

20 November 2013 
                          DIRECTORATE CHANGE                                
Reckitt Benckiser Group plc (RB) today announces the appointment of Nicandro
Durante as an independent non-executive director, effective 1 December 2013 
Mr Durante, Brazilian/Italian, is Chief Executive Officer of British American
Tobacco. (BAT), a FTSE100 company with brands sold in 180 markets. Mr Durante
has had an extensive career at BAT which he joined in 1981. He has held various
commercial and financial roles, becoming Chief Operating Officer in January
2008 and Chief Executive Officer in March 2011. He brings experience of a
highly regulated and innovation-led industry, alongside extensive emerging
markets' experience, having worked in Asia, Africa and Latin America. He adds
further international diversity to the RB board. 
Adrian Bellamy, Chairman of RB, commented 
"The Board is delighted that Nicandro has agreed to join us. He will bring a
wealth of international consumer goods and financial knowledge to the Board and
I am sure he will make a significant contribution to the future success of the
Company." 
There are no further details required to be disclosed pursuant to Listing Rule
9.6.13 in connection with Mr Durante's appointment. 
For Further Information
Andraea Dawson-Shepherd 
SVP Global Corporate Communication and Affairs
Telephone +44 (0) 1753 217 800 
Liz Richardson 
Company Secretary
Telephone +44 (0) 1753 217 800 
About Reckitt Benckiser (RB): 
Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and
home. 
With a purpose of delivering innovative solutions for healthier lives and
happier homes, RB is in the top 25 of companies listed on the London Stock
Exchange. Today it is the global No 1 or No 2 in the majority of its
fast-growing categories, driven by an exceptional rate of innovation. Its
health, hygiene and home portfolio is led by 19 global Powerbrands including
Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil,
Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and
French's. RB has close to half of its revenues coming from it 2 emerging market
Areas and just over half from its developed market Area. Over 70% of core
revenues come from the health and hygiene categories of the portfolio. 
RB people and its culture are at the heart of the company's success. They have
an intense drive for achievement and a desire to outperform wherever they
focus, including in sustainability where the company has reduced its carbon
footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in
water impact, 1/3 further reduction in carbon and to have 1/3 of its net
revenue coming from more sustainable products by 2020. It is also the Save the
Children charity's largest FMCG global partner, with a new partnership vision
to radically reduce the world's second biggest killer of under fives,
diarrhoea. RB has been recognised as a sustainability leader in the CDP Global
500 Carbon Performance Leadership Index and received a 2013 Sector Mover
Sustainability Award in the 10th Sustainability Yearbook. 
The company has operations in over 60 countries, with headquarters in the UK,
Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The company
employs approximately 36,000 people worldwide. 
For more information visit www.rb.com 
END 
-0- Nov/20/2013 13:59 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.